Amalgamated Bank Sells 1,697 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Amalgamated Bank lowered its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 4.1% in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 39,633 shares of the company’s stock after selling 1,697 shares during the quarter. Amalgamated Bank’s holdings in HCA Healthcare were worth $12,733,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also made changes to their positions in the business. Bangor Savings Bank lifted its holdings in HCA Healthcare by 112.5% during the 2nd quarter. Bangor Savings Bank now owns 85 shares of the company’s stock valued at $27,000 after buying an additional 45 shares in the last quarter. MFA Wealth Advisors LLC bought a new stake in shares of HCA Healthcare during the second quarter valued at approximately $27,000. Unique Wealth Strategies LLC purchased a new position in HCA Healthcare during the 2nd quarter worth $28,000. GPS Wealth Strategies Group LLC lifted its holdings in shares of HCA Healthcare by 284.0% in the 2nd quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock worth $31,000 after buying an additional 71 shares during the period. Finally, LifeSteps Financial Inc. purchased a new position in shares of HCA Healthcare during the first quarter valued at $33,000. 62.73% of the stock is currently owned by institutional investors.

Insider Buying and Selling at HCA Healthcare

In related news, SVP Kathryn A. Torres sold 1,857 shares of HCA Healthcare stock in a transaction dated Thursday, July 25th. The stock was sold at an average price of $355.05, for a total value of $659,327.85. Following the completion of the transaction, the senior vice president now owns 17,755 shares in the company, valued at approximately $6,303,912.75. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. In other news, SVP Kathryn A. Torres sold 1,857 shares of the company’s stock in a transaction that occurred on Thursday, July 25th. The stock was sold at an average price of $355.05, for a total transaction of $659,327.85. Following the completion of the transaction, the senior vice president now directly owns 17,755 shares of the company’s stock, valued at approximately $6,303,912.75. The sale was disclosed in a filing with the SEC, which is available at this link. Also, SVP Kathleen M. Whalen sold 2,987 shares of the business’s stock in a transaction on Wednesday, July 31st. The stock was sold at an average price of $363.51, for a total transaction of $1,085,804.37. Following the completion of the sale, the senior vice president now directly owns 9,454 shares of the company’s stock, valued at approximately $3,436,623.54. The disclosure for this sale can be found here. Over the last quarter, insiders sold 17,202 shares of company stock valued at $6,407,273. Corporate insiders own 1.60% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts have commented on the stock. JPMorgan Chase & Co. raised their target price on shares of HCA Healthcare from $327.00 to $332.00 and gave the company a “neutral” rating in a research report on Thursday, May 30th. Truist Financial boosted their price objective on shares of HCA Healthcare from $390.00 to $430.00 and gave the stock a “buy” rating in a research note on Monday, August 19th. Wells Fargo & Company boosted their price target on HCA Healthcare from $315.00 to $365.00 and gave the stock an “equal weight” rating in a research report on Tuesday, July 30th. Morgan Stanley began coverage on HCA Healthcare in a research note on Tuesday, September 3rd. They issued an “equal weight” rating and a $427.00 target price on the stock. Finally, Cantor Fitzgerald restated an “overweight” rating and issued a $392.00 price target on shares of HCA Healthcare in a report on Monday, August 19th. Five analysts have rated the stock with a hold rating, fourteen have issued a buy rating and three have given a strong buy rating to the company. Based on data from MarketBeat.com, HCA Healthcare currently has a consensus rating of “Moderate Buy” and an average target price of $359.89.

HCA Healthcare Stock Performance

Shares of NYSE HCA opened at $399.89 on Thursday. The company has a current ratio of 1.06, a quick ratio of 0.94 and a debt-to-equity ratio of 27.11. The company has a 50 day simple moving average of $367.24 and a two-hundred day simple moving average of $339.56. HCA Healthcare, Inc. has a 12 month low of $215.96 and a 12 month high of $404.90. The stock has a market cap of $104.74 billion, a price-to-earnings ratio of 19.93, a PEG ratio of 1.46 and a beta of 1.67.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Tuesday, July 23rd. The company reported $5.50 earnings per share for the quarter, beating analysts’ consensus estimates of $4.97 by $0.53. The business had revenue of $17.49 billion during the quarter, compared to analyst estimates of $17.05 billion. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. The company’s revenue was up 10.3% on a year-over-year basis. During the same quarter last year, the business posted $4.29 EPS. As a group, analysts predict that HCA Healthcare, Inc. will post 22.46 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, September 30th. Investors of record on Monday, September 16th will be issued a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a yield of 0.66%. The ex-dividend date of this dividend is Monday, September 16th. HCA Healthcare’s dividend payout ratio (DPR) is presently 13.16%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.